Status:

COMPLETED

Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep Apnea

Lead Sponsor:

Apnex Medical, Inc.

Conditions:

Obstructive Sleep Apnea

Eligibility:

All Genders

21-70 years

Phase:

PHASE2

PHASE3

Brief Summary

The overall goal of the study is to evaluate the safety, efficacy and therapy settings of the HGNS System for stimulating the hypoglossal nerve to help maintain an open airway in subjects with obstruc...

Eligibility Criteria

Inclusion

  • Eligibility Criteria
  • Previously diagnosed with moderate to severe obstructive sleep apnea.
  • Subject has failed or does not tolerate CPAP treatment.
  • Age between 21 and 70 years.
  • Body mass index (BMI) less than or equal to 40

Exclusion

    Key Trial Info

    Start Date :

    March 1 2009

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    May 1 2013

    Estimated Enrollment :

    40 Patients enrolled

    Trial Details

    Trial ID

    NCT01186926

    Start Date

    March 1 2009

    End Date

    May 1 2013

    Last Update

    April 15 2015

    Active Locations (0)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 0 (0 locations)

    No Results Found

    We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

    Australian Clinical Study of the Apnex Medical HGNS System to Treat Obstructive Sleep Apnea | DecenTrialz